{"name":"Neuren Pharmaceuticals Limited","slug":"neuren-pharmaceuticals-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNSFR6ZC1YTTRUbjhPb0FnYXhHcWx1ODNuVHhPa2x2dm1QTFFVSWtFQXRXSVBYaHIxRkFXWmZYcThjal90cEJVVTJyeHUyTlExTS01THpCTWpXOEp3c3NibzFlR0VjelRVSnVEOEVzSFhKaFVPTm1lbE9acUk3Z29BeFhyU1o2bUhyNExDa2VVMlRfNWliLTJzTzc3OTR3aWpT?oc=5","date":"2026-03-02","type":"deal","source":"kalkinemedia.com","summary":"Neuren Pharma Update: Buy-Back Plan And Pipeline Focus - kalkinemedia.com","headline":"Neuren Pharma Update: Buy-Back Plan And Pipeline Focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPa3h2Ty1aZTFkWWY0MFFmbUNFZjJZamJQSWJ4bGF2RXJPejJla0ZKdlZjTVFHSDJIdy1hd3BvbWl1dWp6UU5xTG1JSkkzUFhINWQ5X3dLZnlGYl93aldUbE11LXdwN0s1NWVDa3RHZndtNG1YQ3ZKSVhkaTFaLURqNm44REl5QU9HcXBwX05maW9qLS1UY0JSV3NkcmI1d2FNWmFQUkx5ZUNhdTVtbk5YeA?oc=5","date":"2026-02-23","type":"pipeline","source":"kalkinemedia.com","summary":"Is This ASX Biotech in the ASX 300 Emerging Alongside CSL Limited? - kalkinemedia.com","headline":"Is This ASX Biotech in the ASX 300 Emerging Alongside CSL Limited?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQVGw4a3hEVmNzYXhZdFl6VWtnU3ZwTXI5TThGV2l2LVNvNDA3dm5WYzRHT0w2VUMzNnlfMWl2YmtWUTFaMjYzMTV0YktQV3p0OFdBZ3JfWGRfUDVqbW9VdmhWajNWQ1lNQjhDVzVIMTFfSkRKWDhrTzBQUEpOdHgyWEdJczlPY1IzMm5qelo4QUxRelE1MkliV3BhcVNQZ3NIc0hka01XdEpVTTNacnBvaDRabjRXNGNuWjFwaEZodWZsb2ZqY1pEeUFGcUI2SkxaQzJYN2RvLWdkeU1PSkV5RkhvR1R0SEI3bEZpUDV2RW_SAfYBQVVfeXFMTXZCZHJ3cHlfUjEyeHgyUHRGeHpwV0QzeHJ4SUxOTC1yOEFVZF9GaWVtd0E1UDJtVkdhWWhqeEtnbVo0T19GUkpPSzFVWllrWDFMT3NCYjlVVkFCRWE0RFEwaDBNQks0TFRhWHpSaGRETEJpSHJJU21jZzcyVEhFOURxalBFVHpKV1E2bkpvNGtmVzdxc2lHekV2bkoxdlFEZDhDeXBDWUFscHV5Nmt6enl3MEdLQWo2M3paeGZtdG9zbjZ3dmVhZjRmcTkwSk9xMjZ1WVlMTUlzR2tUUXdxWXBWa0pmSXBGTjFuek5NTThsRDhKS1Zn?oc=5","date":"2026-02-05","type":"pipeline","source":"simplywall.st","summary":"Slammed 30% Neuren Pharmaceuticals Limited (ASX:NEU) Screens Well Here But There Might Be A Catch - simplywall.st","headline":"Slammed 30% Neuren Pharmaceuticals Limited (ASX:NEU) Screens Well Here But There Might Be A Catch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQdUZTUFhSSkxFcTJjbUVrS0VuYnplQXB2N2FLNkttLU96a3MxNEJ5dHctQ3AxV2JwN1RKcm9PRnhMY24zZ3pCMkdwejRNVS1EUS1xU2UtajBOWmJRWF93eXhhdmJZbUtHb0Ytdjl0azA0ek9xZDA2VFRxdVNRYnlsT0Y5d0FZVUVHWWJPam9PemdzZkVISnc?oc=5","date":"2026-02-03","type":"pipeline","source":"thebull.com.au","summary":"Neuren Pharmaceuticals Shares Extend Slide on European Setback - thebull.com.au","headline":"Neuren Pharmaceuticals Shares Extend Slide on European Setback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOcjBJeWhSdEJTckdQeGNJQkZ0ckM5Z1A2VXVjaWRFNC1YNlpuaUZLRzU1OHZQTFlkMjFZdjNUY3NMTUdlSmtBeUkzZmlVbnJCZVl2QTZEbTM1TVN1d3FaSXJsb0ZJcTUwOElYX0FiMEo5d3FXRFFBeEJ4UjgxZW56QQ?oc=5","date":"2025-09-26","type":"pipeline","source":"The Motley Fool Australia","summary":"CSL shares fall on new Trump tariff hit - The Motley Fool Australia","headline":"CSL shares fall on new Trump tariff hit","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-02","type":"earnings","source":"simplywall.st","summary":"Investors Shouldn't Be Too Comfortable With Neuren Pharmaceuticals' (ASX:NEU) Earnings - simplywall.st","headline":"Investors Shouldn't Be Too Comfortable With Neuren Pharmaceuticals' (ASX:NEU) Earnings","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-27","type":"pipeline","source":"simplywall.st","summary":"Here's Why We Think Neuren Pharmaceuticals (ASX:NEU) Is Well Worth Watching - simplywall.st","headline":"Here's Why We Think Neuren Pharmaceuticals (ASX:NEU) Is Well Worth Watching","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQaVdYOEJnX3ZQR2RqRDRtUUtFYmU1eVNqQTMxdVh5TG96Smc1NjZzbDBVbENOS0txU2k5a1JhRVo4SVg1d29vZ19jbnc1MzlfWTBiWE9KQXJvZU9SVmJmd0NoZkhacDNZSTNjQWdTRU1TSkk5Nm1nNVp3M3NYbm1WVnJOckItYVFLOE95N3ZYNm5XQkpTNHVBY0s3em5KeHdjbkFrR3NTNjU?oc=5","date":"2025-06-04","type":"pipeline","source":"intelligentinvestor.com.au","summary":"Neuren Pharmaceuticals: Under the Microscope - intelligentinvestor.com.au","headline":"Neuren Pharmaceuticals: Under the Microscope","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPU1hsYmJ3T09fZFJHQ3hhd2kzQ1MtN29YZHVEMTRzbUtFUWNwX0w2d1dKREFYY3VTOC03YWVEQVBvZW1DSGRCSkkxcmtWZ2kyYnYzVXo4RjFXYmhOZW0yOEl5QjFQOTh4dG5XNW9xMThaeFozX3VzQVB0YUw5XzV6V1BFa1p3S3hOTTFLRXlIM0Ytd0xsU1RPTWtfZWdjQ0V1MkpxZFg4Z3ZxMG9MSTBLU1AxNjl5TUtjT0piYzZXSEd6X0xSWWdNZkhfNHhUeWZ1?oc=5","date":"2025-04-24","type":"pipeline","source":"AFR","summary":"NEU ASX: This $1.3b biotech is still run out of a spare bedroom in Melbourne - AFR","headline":"NEU ASX: This $1.3b biotech is still run out of a spare bedroom in Melbourne","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPeUR1clhXZGhJVklnbjdCWWJZZklITVk5RjM5bUJyZmsyRS1MWUt1cGpzOVhucXZLeUc0LUpwVTF0czNNUnFvc192X3I5SVpJaDN2NWNkYmZLcXV3ZXYyUXpCRm9OanNrMEVxUDdCZHVyQ0VDQVhhMlo4alhRM0Rfc05uNnVqX3NCLTV6TTBZb1VUUDdlVU1DTGRTbWZrNHVBTGs4NEpybl9TeHY3ZlVDZW1fZ3FRZ0tjSU5Wbk4zSUt3Y3ZQYk1kakRObTQ?oc=5","date":"2025-04-14","type":"trial","source":"Capital Brief","summary":"Neuren Pharma shares soar on progress for new drug trial - Capital Brief","headline":"Neuren Pharma shares soar on progress for new drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE0ybzFldVFObEREblNjNHRxWHFLTEdCVVFnV2VhWmRvNW14U1RHOW0tYzJfVE1mWDhfT1pLTE5QTVBvb2NkY29hXzcxaGtnS1FIZlpnRUJWMkMzVUZucUhXSy1tMkJYaXVLQ1F6LTdfczhFT2ZiRDRxQjRpOTU0Zw?oc=5","date":"2025-03-01","type":"earnings","source":"Yahoo Finance","summary":"News Flash: 6 Analysts Think Neuren Pharmaceuticals Limited (ASX:NEU) Earnings Are Under Threat - Yahoo Finance","headline":"News Flash: 6 Analysts Think Neuren Pharmaceuticals Limited (ASX:NEU) Earnings Are Under Threat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPcUtXRy00WnBLZWN4NWZnOHhTOEhVMkJDcFJ5MHI2bk8yVi0ycmIzM3l3TlZaZUdKZm9GQ05GVjRCbFNqWUVtYVBORkc0SEVjSHNkeklJc1BfNkhIWGpTazZ2cDZPemFtYk5NdVllTVFTejhvTnhOQTJ5QWJPVkNvMi10UFlmTlNsWWR1eVhoMTFnZkRUa1Ribkx4MDE3bjA?oc=5","date":"2024-11-06","type":"regulatory","source":"MedCity News","summary":"Acadia Pharma Sells Voucher for Speedier FDA Drug Review for $150M - MedCity News","headline":"Acadia Pharma Sells Voucher for Speedier FDA Drug Review for $150M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}